CHICAGO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- INFI USA, a pioneering AI-driven self-service software platform, today announced $12 million in Series A funding to accelerate technological innovation, ...
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and ...
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (OTC: INFIQ) between January 5, ...
Infinity Pharmaceuticals, Inc. INFI provided an update on a placebo-controlled phase II study, MARIO-275, evaluating the benefit of adding eganelisib to Bristol Myers Squibb’s BMY Opdivo (nivolumab) ...
Infinity Pharma INFI announced additional details on the design of its phase II MARIO-8 study, evaluating eganelisib for squamous cell cancer of the head and neck (SCCHN). Shares of the company were ...
Infinity Pharmaceuticals Inc (NASDAQ:INFI) announced further design features of its Phase 2 MARIO-8 study in Squamous Cell Cancer of the Head and Neck (SCCHN). The adaptive design of the MARIO-8 study ...
Road Town, British Virgin Islands--(Newsfile Corp. - January 26, 2024) - In a significant move for cryptocurrency and mobile technology enthusiasts, LBank Exchange, a premier global digital asset ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results